
Healthcare · NSE
Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.
Price Band
₹91 – ₹96
Issue Size
₹58.57 Cr
Lot Size
1200 shares
GMP
+20.8%
Est. Listing
₹116
at current GMP
Subscribed
187.32x
overall
Open
18 Jun 2025
Close
20 Jun 2025
Allotment
23 Jun 2025
Refund
24 Jun 2025
Demat Credit
25 Jun 2025
Listing
25 Jun 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹96
Band: ₹91 – ₹96
Estimated Listing Price
₹116
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,15,200
Estimated Profit / Lot
₹24,000
1200 × ₹20
Grey Market Premium trend
+₹20
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹20 | 20.8% | ₹116 |
| 30 Oct 2026 | +₹20 | 20.8% | ₹116 |
| 29 Oct 2026 | +₹18 | 18.8% | ₹114 |
GMP is unofficial market data. Not a guarantee of listing performance.
Influx Healthtech Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹58.57 Crores. The shares are offered at a price band of ₹91 to ₹96 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-06-20, the basis of allotment is scheduled to be finalized on 2025-06-23. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Maashitla Securities Private Limited) or the BSE allotment checking window.
The latest grey market premium for Influx Healthtech Limited IPO is ₹20, which indicates an expected listing price of ₹116.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.